QKLS yields 2000000.00% · ABBV yields 3.06%● Live data
📍 QKLS pulled ahead of the other in Year 1
Combined, QKLS + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of QKLS + ABBV for your $10,000?
QKL Stores Inc., together with its subsidiaries, operates supermarket chains in northeastern China and Inner Mongolia. Its supermarkets and hypermarkets sell grocery items, such as instant foods, canned foods, packaged rice and wheat powder, crackers and chips, rice and ground wheat, bottled water and beverages, and cigarettes, as well as non-food items, including cleaning products, cosmetics, and disposable razors. The company also sells fresh-food items comprising raw meat, cooked meats, seafood, noodles and pastas, milk, yogurt, eggs, and packaged dumplings, as well as bakery items comprising breads, buns, and other self-prepared foods. In addition, it offers other non-food items, such as clothing and shoes, books and stationery, bedding and home furnishings, office supplies, toys, sporting goods, and other items, as well as electronics and household use items, such as irons, electric shavers, hair dryers, and massage machines. Further, the company operates department stores that sell brand-name and luxury clothing and accessories, cosmetics, small electronics, jewelry, books, home furnishings, and bedding, as well as have a movie theater and a traditional beauty salon. As of December 31, 2015, the company operated 25 supermarkets, 16 hypermarkets, and 4 department stores. QKL Stores Inc. is headquartered in Daqing, the People's Republic of China.
Full QKLS Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.